Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04CFL
|
|||
| Drug Name |
SB 242784
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Arterial calcification [ICD-11: BD52.Y] | Preclinical | [1] | |
| Company |
SmithKline Beecham Biologicals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Vacuolar-type proton ATPase (v-ATPase) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat. Circ Res. 2002 Sep 20;91(6):547-52. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.